Research-based life sciences company, Kyowa Kirin Asia Pacific Pte Ltd., a Japan-based, wholly owned subsidiary of Kyowa Hakko Kirin Co Ltd, announced yesterday that it has established an Australian subsidiary, named Kyowa Kirin Australia Pty Ltd (Kyowa Kirin Australia).
With the establishment of Kyowa Kirin Australia, Kyowa Kirin Asia Pacific aims to launch Kyowa Hakko Kirin's global strategic products in the country.
Chikakuni Kotani, president of Kyowa Kirin Asia Pacific said, 'It is our pleasure to announce we have incorporated our subsidiary in Australia. It was announced last month that Kyowa Kirin Group will be shifting to a new global management structure under the 'One Kyowa Kirin' policy. Kyowa Kirin Group will be organised into four regions: North America, EMEA, Asia Pacific and Japan, and business expansion will be accelerated globally. This is Kyowa Kirin Asia Pacific's first entry into Oceania and we are excited about the future possibilities. We believe Kyowa Kirin Australia will contribute to the health and well-being of patients and families in Australia.'1.html
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar